Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate

被引：0
|
作者：
Kaeley, Gurjit S. [1 ]
Ranganath, Veena K. [2 ]
MacCarter, Daryl K. [3 ]
Pangan, Aileen L. [4 ]
Wang, Xin [4 ]
Kalabic, Jasmina [5 ]
机构：
[1] Univ Florida, Jacksonville, FL USA
[2] Univ Calif Los Angeles, Los Angeles, CA USA
[3] North Valley Hosp, Whitefish, MT USA
[4] AbbVie Inc, N Chicago, IL USA
[5] AbbVie Deutschland GmbH & Co KG, Ludwigshafen, Germany
来源：
ARTHRITIS & RHEUMATOLOGY | 2016年 / 68卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
640
引用
收藏
页数：4
相关论文
共 50 条
  • [1] CLINICAL RESPONSES AND SYNOVIAL VASCULARITY IN OBESE RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB AND METHOTREXATE
    Kaeley, G. S.
    Ranganath, V. K.
    MacCarter, D. K.
    Pangan, A. L.
    Wang, X.
    Kalabic, J.
    ANNALS OF THE RHEUMATIC DISEASES, 2016, 75 : 1006 - 1007
  • [2] Clinical Responses and Synovial Vascularity in Obese Rheumatoid Arthritis Patients Treated with Adalimumab and Methotrexate
    Kaeley, Gurjit S.
    MacCarter, Daryl K.
    Pangan, Aileen L.
    Wang, Xin
    Kalabic, Jasmina
    Ranganath, Veena K.
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (12) : 1628 - 1635
  • [3] METHOTREXATE REDUCES IMMUNOGENICITY IN ADALIMUMAB TREATED RHEUMATOID ARTHRITIS PATIENTS
    Krieckaert, C.
    Nurmohamed, M. T.
    Wolbink, G.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 71 : 101 - 102
  • [4] Treating Rheumatoid Arthritis to Target: Outcomes and Predictors in Early Rheumatoid Arthritis Patients Treated with Adalimumab Plus Methotrexate, Methotrexate Alone, or Methotrexate Plus Subsequent Adalimumab
    Smolen, Josef
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Wolfe, Benjamin
    Kavanaugh, Arthur
    ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S665 - S665
  • [5] TREATING RHEUMATOID ARTHRITIS TO TARGET: OUTCOMES AND PREDICTORS IN EARLY RHEUMATOID ARTHRITIS PATIENTS TREATED WITH ADALIMUMAB PLUS METHOTREXATE, METHOTREXATE ALONE OR METHOTREXATE PLUS SUBSEQUENT ADALIMUMAB
    Smolen, Josef S.
    Fleischmann, Roy M.
    Emery, Paul
    van Vollenhoven, Ronald F.
    Guerette, Benoit
    Santra, Sourav
    Kupper, Hartmut
    Redden, Laura
    Kavanaugh, Arthur
    RHEUMATOLOGY, 2012, 51 : 114 - 115
  • [6] CHANGES IN ULTRASONOGRAPHIC VASCULARITY UPON INITIATION OF ADALIMUMAB COMBINATION THERAPY IN RHEUMATOID ARTHRITIS PATIENTS WITH INADEQUATE RESPONSE TO METHOTREXATE
    Kaeley, G. S.
    Nishio, M. J.
    Goyal, J. R.
    MacCarter, D. K.
    Wells, A. F.
    Cardoso, A.
    Chen, S.
    Kalabic, J.
    Kupper, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 469 - 469
  • [7] Changes in Ultrasonographic Vascularity Upon Initiation of Adalimumab Combination Therapy in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
    Kaeley, Gurjit S.
    Nishio, Midori J.
    Goyal, Janak R.
    MacCarter, Daryl K.
    Wells, Alvin F.
    Chen, Su
    Kupper, Hartmut
    Kalabic, Jasmina
    ARTHRITIS & RHEUMATOLOGY, 2016, 68 (11) : 2584 - 2592
  • [8] Methotrexate reduces immunogenicity in adalimumab treated rheumatoid arthritis patients in a dose dependent manner
    Krieckaert, Charlotte L.
    Nurmohamed, Michael T.
    Wolbink, Gerrit Jan
    ANNALS OF THE RHEUMATIC DISEASES, 2012, 71 (11) : 1914 - 1915
  • [9] Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate- or methotrexate-treated rheumatoid arthritis patients in OPTIMA
    Skapenko, A.
    Smolen, J. S.
    Kavanaugh, A.
    Arora, V.
    Kupper, H.
    Schulze-Koops, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2019, 37 (05) : 783 - 790
  • [10] Chronic hepatitis E in a patient with rheumatoid arthritis treated with adalimumab and methotrexate
    van Bijnen, Sandra T. A.
    Ledeboer, Michiel
    Martens, Henk A.
    RHEUMATOLOGY, 2017, 56 (03) : 497 - 498
12345